Galera Therapeutics receives Nasdaq delisting notice; trading to suspend June 4

Galera Therapeutics, Inc.

Notice from Nasdaq on May 31, 2024 for failure to meet minimum market value, bid price, and publicly held shares requirements.
Nasdaq will suspend trading of common stock (GRTX) at open on June 4, 2024.
Company expects common stock to be quoted on OTC Markets under symbol GRTX.
Company has the right to request a review of the Nasdaq Hearings Panel's decision.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.